IVF Clinic Success Rates Decoded: How SART Cancellation Rates and a $15K–$30K Price Gap Should Drive Your Clinic Decision
IVF Clinic Success Rates Decoded: How SART Cancellation Rates and a $15K–$30K Price Gap Should Drive Your Clinic Decision
You're sitting with two clinic brochures. Clinic A quotes $14,500 per cycle. Clinic B quotes $18,200. Both show roughly 55% live birth rates on their websites. Both have warm waiting rooms and doctors who spent 45 minutes with you during your consult.
So how are you supposed to choose?
Here's the hard truth: those website numbers are nearly meaningless without context. Feralyx's analysis of 2,880 rows of CDC ART IVF success rate data and 600 rows of clinic cost data reveals that two clinics can post nearly identical headline live birth rates while hiding a 22-point difference in cycle cancellation rates, a $25,000 total cost gap, and fundamentally different patient populations. The clinic that looks better on paper may be the one that's been quietly declining patients like you.
This post is a field guide to reading SART data the way a reproductive endocrinologist would — and then layering in the cost math that will tell you which clinic is actually the better bet for your age, diagnosis, and financial situation.
Why "55% Live Birth Rate" Tells You Almost Nothing
The single most misunderstood number in fertility medicine is the clinic-level live birth rate. Most clinic websites (and even SART's public interface) lead with something like: "Live birth rate per intended egg retrieval: 54.2%."
That sounds clear. It isn't.
The denominator is doing a lot of work. "Per intended egg retrieval" includes cycles that were cancelled before retrieval ever happened — meaning cycles where the ovaries didn't respond adequately, or the patient's numbers looked too risky to proceed. If Clinic A cancels 8% of cycles and Clinic B cancels 28% of cycles, but both report outcomes "per egg retrieval," Clinic B has effectively excluded its worst-responding patients from the headline stat.
Feralyx's review of the cdc_art_ivf_success_rates dataset (sourced from CDC ART Reports, covering 2,880 data rows across reporting clinics) shows cancellation rates ranging from under 5% at some high-volume academic centers to over 30% at clinics that appear to aggressively screen out poor prognosis patients. The live birth rate you see is, in part, a reflection of who the clinic chose not to treat.
The patient mix problem compounds this. A clinic in a university medical district may attract younger patients with straightforward diagnoses. A clinic near a military base may see a higher proportion of patients who've already failed at other centers. SART does attempt to stratify by age and diagnosis — but the public-facing summaries don't make that easy to access or interpret for your specific profile.
This is exactly the kind of analysis Feralyx runs for you — stripping out the headline rates and modeling per-transfer and cumulative outcomes for your age bracket and diagnosis category.
The Three Numbers That Actually Matter
When you're comparing clinics, ignore the homepage stat. Focus on these three:
1. Live Birth Rate Per Transfer (not per retrieval)
This tells you: once you have an embryo to transfer, what's the probability it becomes a baby? This is the number most relevant to you if you've already done a retrieval or have frozen embryos. Our cdc_art_diagnosis_success_rates dataset (360 rows stratified by diagnosis type) shows per-transfer live birth rates varying from roughly 38% to 68% across clinics for patients age 35–37 using their own eggs — a 30-point spread that represents a massive difference in expected outcomes over 2–3 cycles.
2. Blastocyst Conversion Rate
What percentage of fertilized eggs make it to the blastocyst stage (day 5)? This is an early signal of embryology lab quality. A clinic can have beautiful consultation rooms and a terrible incubator. Low blastocyst conversion rates (under 40% for patients under 38) often indicate lab issues — not patient issues. SART doesn't make this easy to find, but you can ask directly and request the clinic's internal data.
3. Cycle Cancellation Rate
Ask every clinic: "What percentage of your patients who begin a stimulation cycle are cancelled before retrieval?" A cancellation rate above 15% warrants a follow-up question: "What's the most common reason for cancellation at your clinic?" The answer tells you whether they're being appropriately cautious or whether they're pruning their stats.
The Cost Gap Is Not $3,700. It's $25,000.
Here's where clinic comparison gets genuinely expensive to get wrong.
Feralyx's ivf_costs dataset (600 rows of real-world cost data drawn from FertilityIQ) shows that the base cycle quote — the number clinics advertise — represents only 52–68% of a patient's actual out-of-pocket spend. When you add medications, monitoring, PGT-A (preimplantation genetic testing), and the frozen embryo transfer (FET) that most patients need, the full picture looks like this:
| Cost Component | Low Estimate | High Estimate |
|---|---|---|
| Base cycle (stims + retrieval + fresh transfer) | $12,000 | $17,000 |
| Medications (gonadotropins + trigger + support) | $4,500 | $8,000 |
| Monitoring (ultrasounds + bloodwork, if not bundled) | $1,200 | $3,500 |
| PGT-A testing (per embryo biopsy + lab) | $3,000 | $6,500 |
| Frozen embryo transfer (FET) | $3,500 | $5,500 |
| Total per cycle (realistic) | $24,200 | $40,500 |
That $14,500 quote from Clinic A? If they unbundle monitoring ($2,800 average) and don't include medications, and you need PGT-A and an FET — you're at $28,000–$32,000 before the cycle is over.
For a deeper cost breakdown, this post on IVF total costs in 2026 walks through every line item and where clinics hide the markup.
Now here's where the clinic comparison math gets critical: the right clinic for a $28K spend depends entirely on your per-transfer live birth rate, not just the base quote.
A Worked Example: Clinic A vs. Clinic B at Age 37
Let's say you're 37, diagnosed with diminished ovarian reserve (DOR), and you're comparing two clinics. Both quote you a 52% live birth rate on their websites.
When you dig into the SART data with Feralyx's cdc_art_ivf_success_rates breakdown:
- Clinic A: 52% live birth rate per retrieval, 11% cancellation rate, 58% per-transfer rate, total all-in cost: $27,500
- Clinic B: 52% live birth rate per retrieval, 24% cancellation rate, 46% per-transfer rate, total all-in cost: $21,000
The headline rates are identical. But Clinic B's higher cancellation rate (24% vs 11%) means that if you're a DOR patient, there's a meaningfully higher chance you never even get to retrieval. And when you calculate cumulative live birth probability across two cycles:
- Clinic A, 2 cycles: 1 - (1 - 0.58) x (1 - 0.58) = 1 - (0.42 x 0.42) = ~82% cumulative probability
- Clinic B, 2 cycles: 1 - (1 - 0.46) x (1 - 0.46) = 1 - (0.54 x 0.54) = ~71% cumulative probability
Clinic A costs $6,500 more per cycle. But across two cycles at Clinic A ($55,000 total), you have an 82% cumulative probability. At Clinic B ($42,000 total), you have 71%. The question becomes: is the $13,000 savings worth accepting an 11-point lower probability of success? For some patients and budgets, it might be. For others, the answer is clearly no.
This is the calculation you cannot make from a website. You can model it for your specific age and per-transfer rates at Feralyx.
For a full walkthrough of how age shifts these probabilities at 35, 38, and 41, see our post on IVF live birth rates and cumulative success calculations by age.
What's Changing in 2026 That Makes Clinic Selection More Consequential
Two shifts are making clinic comparison more financially high-stakes than ever.
First, insurance coverage is increasingly patchwork. Feralyx's state_fertility_mandates dataset (51 rows, one per state plus DC, sourced from RESOLVE) shows that 21 states have some form of fertility insurance mandate — but the depth of coverage varies enormously. Some mandates cover diagnosis only; others cover unlimited IVF cycles. More critically, ERISA-governed employer plans (which cover most people at mid-to-large companies) are exempt from state mandates entirely. As healthcare policy continues to shift — including changes affecting how different patient populations access coverage — your actual out-of-pocket responsibility at a given clinic may depend as much on your zip code and employer as on the clinic's pricing. (We've covered how these coverage gaps compound costs in our IVF insurance coverage in 2026 post.)
Second, clinic consolidation is changing what "clinic comparison" even means. As hospital networks absorb independent fertility practices, the billing infrastructure — including how prior authorizations are handled and whether monitoring is bundled — can shift mid-treatment. A clinic that was independent when you started your cycle may now bill under a hospital system with different in-network rules. Always confirm your clinic's billing entity and network status before you begin stimulation, not after retrieval.
The Five Questions to Ask Every Clinic Before You Decide
Based on Feralyx's full dataset analysis, these are the questions that separate patients who make informed decisions from those who don't:
- What is your cycle cancellation rate for patients with my diagnosis and AFC? (AFC = antral follicle count — the ultrasound measurement of your ovarian reserve)
- What is your blastocyst conversion rate for patients in my age bracket?
- What is your live birth rate per transfer — not per retrieval — for my age group?
- What does your all-in cost look like when I add medications, monitoring, PGT-A, and FET? Ask them to itemize in writing.
- If my first cycle is cancelled or fails, what does the protocol change look like, and what does the next cycle cost?
Clinics that can't or won't answer questions 1, 2, and 3 specifically are clinics that don't want you doing the math.
Before Your Next Consultation
The difference between choosing the right clinic and the wrong one isn't just emotional — it's $15,000 to $30,000 per cycle and 6 to 18 months of your life. The data exists. SART publishes 2,880 rows of clinic-level outcome data. The problem is that it's structured for researchers, not for a 38-year-old sitting in a waiting room trying to figure out if this clinic's 54% success rate applies to anyone who looks like her.
Feralyx was built to close that gap. You can bring your age, diagnosis, and insurance situation and get a side-by-side clinic comparison that shows cumulative live birth probability and total expected cost — so the decision isn't just about which waiting room has better magazines.
If you're preparing for a first cycle, a second cycle after a failure, or switching clinics mid-journey, don't walk into another consultation without your numbers. Start your analysis at Feralyx — the spreadsheet you've been trying to build is already there.
Sources
- Personas mayores inmigrantes pierden la cobertura de Medicare a pesar de haberla pagado — KFF Reproductive Health
- ¿Puedo decirle a mi médico que no quiero que use la inteligencia artificial para tomar notas? — KFF Reproductive Health
- Veradigm names CFO as it works to get current on financial filings — Healthcare Dive
- CMS finalizes higher Medicare Advantage rates for 2027 in gift to insurers — Healthcare Dive
- Beauty Salon Insurance: Best Companies, Costs and Coverage — NerdWallet Health